期刊文献+

乏氧诱导因子-1α在不可手术宫颈癌中表达水平与放化疗效果的相关性研究

Study on the Correlation between the Expression Level of Hypoxia-inducible Factor-1α in Inoperable Cervical Cancer and Curative Effect of Radiotherapy and Chemotherapy
下载PDF
导出
摘要 目的:探究乏氧诱导因子-1α(HIF-1α)的表达水平与不可手术宫颈癌患者放化疗后短期、长期预后的关联性。方法:选取本院2012年6月-2015年6月收治的不可手术并接受放化疗综合治疗措施的宫颈癌患者134例,通过特异性HIF-1α抗体检测癌组织内HIF-1α的表达情况,将其分为HIF-1α表达(-)组和HIF-1α表达(+)组,两组患者均于放化疗后4周予以短期疗效评判;然后随访2年,统计患者局部控制率与生存率,分析评估HIF-1α的表达水平对放化疗后短期及长期预后的影响。结果:134例的不可手术的宫颈癌患者中,HIF-1α表达(-)者共35例(26.1%),包括Ⅱ期19例、Ⅲ期12例、IVa期4例;HIF-1α表达(+)者共99例(73.9%),包括Ⅱ期47例、Ⅲ期37例、IVa期15例。短期疗效分析显示:HIF-1α表达(-)组肿瘤治疗有效率为91.4%(32/35),明显高于HIF-1α表达(+)组的79.8%(79/99)(x^2=7.24,P<0.05)。长期疗效分析:HIF-1α表达(-)组2年局控率为88.6%(31/35)高于HIF-1α表达(+)组的75.8%(75/99)(x^2=4.892,P<0.05);HIF-1α表达(-)组2年生存率为94.3%,明显高于HIF-1α表达(+)组的78.8%(x^2=6.134,P<0.05)。结论:HIF-1α的表达水平与不可手术宫颈癌放化疗短期、长期疗效之间存在关联性;HIF-1α表达(-)的患者接受放化疗后,短期有效率、2年局控率、2年生存率均高于HIF-1α表达(+)的患者;因此HIF-1α可考虑作为不可手术宫颈癌患者疗效预测的生物标志物之一。 Objective:To investigate the relationship between the expression level of hypoxia inducible factor-1α(HIF-1α) and short-term and long-term prognosis of patients with inoperable cervical cancer after radiochemotherapy.Method:A total of 134 patients with cervical cancer who were treated with radiotherapy and chemotherapy were enrolled in our hospital from June 2012 to June 2015.The expression of HIF-1α in cancer tissues was detected by specific HIF-1α antibody,the patients were divided into two groups:HIF-1α(-) group and HIF-1α(+) group.Both groups were evaluated short-term after 4 weeks of radiotherapy and chemotherapy.Then,the local control rate and survival rate were analyzed,and the effect of HIF-1α expression on the shortterm and long-term prognosis after radiotherapy and chemotherapy was analyzed and evaluated.Result:Totally 35 cases(26.1%) had HIF-1α expression(-) in 134 cases of unresectable cervical cancer,including 19 cases of stage Ⅱ,12 cases of stage Ⅲ and 4 cases of stage Iva.The expression of HIF-1α expression(+)99 cases(73.9%),including 47 cases of stage Ⅱ,37 cases of stage Ⅲ and 15 cases of stage Iva.Short-term curative effect analysis showed that the effective rate of tumor treatment in the HIF-1 α expression(-) group was 91.4%(32/35),which was significantly higher than 79.8%(79/99) in the HIF-1α expression(+)group( x^2=7.24,P0.05).Long-term therapeutic analysis:the 2-year local control rate was 88.61%(31/35)in the HIF-1α expression(-) group,which was higher than 79.8%(75/99) in the HIF-1α expression(+)group( x^2=4.892,P0.05);the 2-year survival rate of HIF-1α expression(-) group was 94.3%,which was significantly higher than 78.8% of HIF-1 α expression(+) group( x^2=6.134,P0.05).Conclusion:There is a correlation between the expression level of HIF-1α and the short-term and long-term curative effect of radiotherapy and chemotherapy for inoperable cervical cancer.Short-term effective rate,2-year local control rate,2-year survival rates were higher than those with HIF-1α expression(+);therefore,HIF-1α could be considered as one of the biomarkers for predicting the efficacy of inoperable cervical cancer.
作者 谢福川 邵汛帆 张弛 肖伟 XIE Fuchuan;SHAO Xunfan;ZHANG Chi(Huizhou Municipal Center Hospital,Huizhou 516001,China)
出处 《中国医学创新》 CAS 2018年第11期14-18,共5页 Medical Innovation of China
关键词 HIF-1Α 宫颈癌 放疗 化疗 关联性分析 HIF-1α Cervical cancer Radiotherapy Chemotherapy Correlation analysis
  • 相关文献

参考文献3

二级参考文献15

  • 1Gordan JD, Simon MC. Hypoxia-inducible factors: central regula- tors of the tumour phenotype [J]. Curt Opin Genet Dev, 2007, 17(1) :71-77.
  • 2Mazzaferri EL. A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissec- tions and selective use of radioiodine [ J ]. J Clin Endocrinol Metab, 2009, 94(4): 1086-1088.
  • 3Dehnc N, Fuhrmann D, Brune B. Hypoxia-indueible factor (HIF) in hormone signaling during health and disease [ J]. Card- iovase Hematol Agents Med Chem, 2013, 1 1 (2) : 125-135.
  • 4Murphy B J, Kimura T, Sato BG,et al. Mctallothionein induction by hypoxia involves cooperative interactions between metal-respon- sive transcription factor-1 and hypoxia-inducible transcription fac- tor-1 alpha [ J]. Mol Cancer Res, 2008, 6(3) : 483-490.
  • 5Kojima I, Tanaka T, Inagi R,et al. Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidney [ J]. Kidney Int, 2009, 75 (3): 268-277.
  • 6Burrows N, Resch J, Cowen RL,et al. Expression of hypoxia-in-ducible factor 1 alpha in thyroid carcinoma [ J]. Endocr-Relat Cancer, 2010, 17(1): 61-72.
  • 7Mo JH, Choi IJ, Jeong WJ,et al. HIF-la and HSP90: target mol- ecules selected from a tumorigenic papillary thyroid carcinoma cell line [J]. Cancer Sci, 2012, 103(3) : 464-471.
  • 8Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis [ J]. Clin Cancer Res, 2010, 16 (24) : 5928-5935.
  • 9Raval RR, Tran MG, Sowter HM,et al. Contrasting properties of hypoxia-inducible factor Ⅰ ( HIF-Ⅰ ) and HIF-2 in yon Hippel-Lin- dau-associated renal cell eareinoma[ J]. Mol Cell Biol, 2005, 25 ( 13 ) : 5678-5686.
  • 10Holmquist-Mengelbier L, Lofstedt T, Noguera R,et al. Recruit- ment of HIF-1 alpha and HIF-2 alpha to common target genes is differentially regulated in neuroblastoma: HIF-2 alpha promotes an aggressive phenotype [ J ]. Cancer Cell, 2007, 10 ( 5 ) : 413-423.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部